Xgeva 120 MG/1.7 ML vial 1.7ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9S20
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $41,397
Award facts
- Contract value 100% obligated
- $41,396.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $41,396.88 to AmerisourceBergen Drug Corp for the supply of XGEVA 120 mg/1.7 ml vials. This competitively awarded, firm fixed-price contract was issued on December 23, 2025, with completion expected by December 24, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. XGEVA is a bone-targeted agent used in oncology care to prevent skeletal-related events in patients with certain cancers, making it a specialized pharmaceutical product critical to military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the contractor to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor headquartered in Pennsylvania, maintains an established track record of fulfilling federal medical procurement requirements through competitively awarded contracts with DLA.
Quick answers
Who was awarded contract SPE2DR26F9S20?
SPE2DR26F9S20 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26F9S20 worth?
The government has obligated $41,397 on SPE2DR26F9S20.
Is contract SPE2DR26F9S20 an order under another contract?
Yes. SPE2DR26F9S20 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9S20 competed?
The extent of competition for SPE2DR26F9S20 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award